Table of Contents Table of Contents
Previous Page  489 / 1601 Next Page
Information
Show Menu
Previous Page 489 / 1601 Next Page
Page Background

LARTIA TRIAL

• 217 patients

• 50 adapted

• Median dose 60Gy

• Median follow-up 25.8 months

• 30% local recurrence rate

• 20% infield

• 6% marginal

• 4% out of field

Ramella et al. JTO, 2018